Emactuzumab |
RG-7155; 6FY6EI1X8R; RO-5509554 |
Phase 1 Clinical |
F. Hoffmann-La Roche Ltd |
Neoplasms; Lymphoma, Non-Hodgkin |
Details
|
Recombinant human GM-CSF oncolytic herpes simplex virus type 2 (OH2) |
|
Phase 2 Clinical |
Wuhan Binhui Biotechnology Co Ltd |
Head and Neck Neoplasms; Carcinoma, Renal Cell; Pancreatic Neoplasms; Digestive System Neoplasms; Sarcoma; Breast Neoplasms; Lymphoma; Lung Neoplasms; Melanoma |
Details
|
Q-702 |
|
Phase 1 Clinical |
Qurient Co Ltd |
Solid tumours; Neoplasm Metastasis |
Details
|
DCC-3014 |
DCC-3014 |
Phase 2 Clinical |
Deciphera |
Giant Cell Tumor of Tendon Sheath; Synovitis, Pigmented Villonodular |
Details
|
Cilmostim |
CSF-1 |
Phase 3 Clinical |
Pfizer Pharmaceuticals Ltd (China) |
Hypercholesterolemia; Presbyopia |
Details
|
TPX-0022 |
TPX-0022 |
Phase 1 Clinical |
Turning Point Therapeutics |
Neoplasms |
Details
|
Vorolanib |
CM-082; X-82 |
Phase 3 Clinical |
Tyrogenex |
Kidney Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Pancreatic neuroendocrine tumors (pNET); Small Cell Lung Carcinoma; Retinal Diseases; Wet Macular Degeneration; Thymoma; Leukemia, Myeloid, Acute; Retinal Degeneration; Melanoma; Macular Degeneration; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Choroidal Neovascularization |
Details
|
SOMCL-15-290 |
SOMCL-15-290 |
Phase 1 Clinical |
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences |
Biliary Tract Neoplasms; Stomach Neoplasms; Carcinoma, Transitional Cell; Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell |
Details
|
LY-3022855 |
IMC-CS4; LY-3022855 |
Phase 2 Clinical |
Eli Lilly And Company |
Neoplasms; Neoplasm Metastasis; Melanoma |
Details
|
PMI-04 |
|
Phase 1 Clinical |
Precision Molecular |
Nerve Degeneration |
Details
|
AMG-820 |
AMG-820 |
Phase 2 Clinical |
Amgen Inc |
Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
BLZ-945 |
BLZ-945 |
Phase 2 Clinical |
Novartis Pharma Ag, Celgene Corp |
Neoplasms; Amyotrophic Lateral Sclerosis |
Details
|
Edicotinib |
JNJ-244; JNJ-527; PRV-6527; JNJ-40346527 |
Phase 2 Clinical |
Johnson & Johnson |
Arthritis, Rheumatoid; Hodgkin Disease; Leukemia, Myeloid, Acute; Crohn Disease |
Details
|
Cabiralizumab |
FPA-008; ONO-4687; BMS-986227 |
Phase 2 Clinical |
Five Prime Therapeutics |
Giant Cell Tumor of Tendon Sheath; Ovarian Neoplasms; Head and Neck Neoplasms; Lymphoma, T-Cell, Peripheral; Biliary Tract Neoplasms; Synovitis, Pigmented Villonodular; Carcinoma, Renal Cell; Arthritis, Rheumatoid; Pancreatic Neoplasms; Glioma; Melanoma; Carcinoma, Non-Small-Cell Lung |
Details
|
ABSK-021 |
ABSK-021 |
Phase 1 Clinical |
Abbisko Therapeutics |
Neoplasms |
Details
|
NMS-03592088 |
NMS-P088; NMS-03592088 |
Phase 2 Clinical |
Nerviano Medical Sciences |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute |
Details
|
PLX-7486 |
PLX-7486; PLX7486-TsOH |
Phase 1 Clinical |
Daiichi Sankyo Co Ltd |
Giant Cell Tumor of Tendon Sheath; Solid tumours; Pancreatic Neoplasms |
Details
|
Axatilimab |
SNDX-6352; UCB-6352 |
Phase 2 Clinical |
Ucb |
Cytokine Release Syndrome; Solid tumours; Graft vs Host Disease; Respiratory Distress Syndrome, Adult; Coronavirus Infections; Neoplasm Metastasis |
Details
|
Linifanib |
RG-3635; A-741439; AL-39324; ABT-869 |
Phase 2 Clinical |
Abbvie Inc |
Liver Neoplasms; Solid tumours; Carcinoma, Renal Cell; Carcinoma; Rectal Neoplasms; Neoplasms, Glandular and Epithelial; Colonic Neoplasms; Liver Diseases; Digestive System Neoplasms; Endometriosis; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Adenocarcinoma; Macular Degeneration |
Details
|
ARRY-382 |
ARRY-382 |
Phase 2 Clinical |
Celgene Corp, Array Biopharma |
Solid tumours; Neoplasm Metastasis |
Details
|
Pacritinib |
SB-1518; ONX-0803 |
Phase 3 Clinical |
Syncore Biotechnology Co Ltd, Concert |
Lymphoma, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Polycythemia Vera; Hodgkin Disease; Myelodysplastic Syndromes; Myeloproliferative Disorders; Leukemia, Myelomonocytic, Chronic; Coronavirus Disease 2019 (COVID-19); Lymphoma, Mantle-Cell; Coronavirus Infections; Primary Myelofibrosis; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Lymphoma; Thrombocythemia, Essential |
Details
|